BIOLOGICAL SAFETY

RESEARCH & ECONOMIC DEVELOPMENT

Program provides guidance for minimizing health and environmental exposures to biological hazards, oversight for research with biological materials, and compliance with the OSHA Bloodborne Pathogen standard. The Institutional Biosafety Committee (IBC) is responsible for reviewing all University activities involving the use of biohazards, recombinant DNA, select agents, and bloodborne pathogens. The IBC evaluates risk and defines containment and practices for safe work with infectious agents and biologically derived infectious materials.

The Biological Safety Specialist is Madeline Dalrymple.

---

Biological Safety Program Pages

• Institutional Biological Safety Committee (IBC)

  • Biological Agents

  • Biological Toxins

  • Recombinant DNA

  • Select Agents

• Bloodborne Pathogens Standard (occupational exposure to human tissues)

• Dual User Research of Concern (DURC) Institutional Review Entity (IRE)

 Biological Safety Procedures

• Restarting Research Checklist

• Procedures for Registering Research with the Institutional Biosafety Committee

• Biological Exposure & Reporting Instructions

• Biosafety Cabinets

• Biosafety Manual Draft 2018-11

• Federal Guidelines and Regulations Pertaining to Biological Science

• Sharps Safe Handling and Disposal Guidelines

• Standard Operating Procedure for Autoclave Operation

• Dual User Research of Concern (DURC)

Biological Safety Training

• Bloodborne Pathogens Training

• CITI Training for Research Instructions (After following steps 1-9, scroll down to Item # 15 for Biosafety)

Biological Safety Related Pages

• Biological Safety External Links